Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Faye J. Sheen is active.

Publication


Featured researches published by Faye J. Sheen.


Organic Process Research & Development | 2011

The First Large-Scale Synthesis of MK-4305: A Dual Orexin Receptor Antagonist for the Treatment of Sleep Disorder

Carl A. Baxter; Ed Cleator; Karel M. J. Brands; John S. Edwards; Robert A. Reamer; Faye J. Sheen; Gavin W. Stewart; Neil A. Strotman; Debra J. Wallace


Journal of Organic Chemistry | 2006

Practical Asymmetric Synthesis of a γ-Secretase Inhibitor Exploiting Substrate-Controlled Intramolecular Nitrile Oxide−Olefin Cycloaddition

Jeremy P. Scott; Steven F. Oliver; Karel M. J. Brands; Sarah E. Brewer; Antony J. Davies; Andrew D. Gibb; David Hands; Stephen P. Keen; Faye J. Sheen; Robert A. Reamer; Robert Darrin Wilson; Ulf-H. Dolling


Organic Process Research & Development | 2015

Evolution of a Manufacturing Route to Omarigliptin, A Long-Acting DPP‑4 Inhibitor for the Treatment of Type 2 Diabetes

John Chung; Jeremy P. Scott; Camille Anderson; Brian Bishop; Nadine Bremeyer; Yang Cao; Qinghao Chen; Robert F. Dunn; Amude Kassim; David R. Lieberman; Aaron Moment; Faye J. Sheen; Michael J. Zacuto


Tetrahedron Letters | 2010

Synthesis of novel benzoxathiazepine-1,1-dioxides by means of a one-pot multicomponent reaction

Ed Cleator; Carl A. Baxter; Michael O’Hagan; Timothy J.C. O’Riordan; Faye J. Sheen; Gavin William Stewart


Archive | 2012

Crystalline forms of a dipeptidyl peptidase-IV inhibitor

Itzia Z. Arroyo; Davida Krueger; Ping Chen; Aaron Moment; Tesfaye Biftu; Faye J. Sheen; Yanfeng Zhang


Organic Process Research & Development | 2009

Development of a Scaleable Synthesis of a Partial Nicotinic Acid Receptor Agonist

Robert Darrin Wilson; Ed Cleator; Michael S. Ashwood; Matthew M. Bio; Karel M. J. Brands; Antony J. Davies; Ulf-H. Dolling; Khateeta M. Emerson; Andrew D. Gibb; David Hands; Arlene E. McKeown; Steven F. Oliver; Robert A. Reamer; Faye J. Sheen; Gavin W. Stewart; George Zhou


Archive | 2012

Process for preparing chiral dipeptidyl peptidase-IV inhibitors

Michael J. Zacuto; Robert F. Dunn; Aaron Moment; Jacob M. Janey; David R. Lieberman; Faye J. Sheen; Nadine Bremeyer; Jeremy P. Scott; Jeffrey T. Kuethe; Lushi Tan; Qinghao Chen


Tetrahedron Letters | 2006

Regioselective synthesis of N-substituted-4-substituted isothiazolidine-1,1-dioxides

Ed Cleator; Faye J. Sheen; Matthew M. Bio; K.M. Jos Brands; Antony J. Davies; Ulf-H. Dolling


Tetrahedron | 2009

Regioselective coupling reactions of 2,4-diaminopyridine derivatives with aryl halides: the synthesis of elaborated pyridines

Matthew M. Bio; Ed Cleator; Antony J. Davies; Simon E. Hamilton; Andrew Lawrence; Faye J. Sheen; Gavin William Stewart; Robert Darrin Wilson


Organic Process Research & Development | 2012

Process Development and Large-Scale Synthesis of MK-6186, a Non-Nucleoside Reverse Transcriptase Inhibitor for the Treatment of HIV

Adrian Goodyear; Xin Linghu; Brian Bishop; Cheng Chen; Ed Cleator; Mark McLaughlin; Faye J. Sheen; Gavin W. Stewart; Yingju Xu; Jingjun Yin.

Collaboration


Dive into the Faye J. Sheen's collaboration.

Researchain Logo
Decentralizing Knowledge